within Pharmacolibrary.Drugs.ATC.J;

model J01CA16
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00015999999999999999,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0135,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01CA16</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sulbenicillin is a semisynthetic, broad-spectrum penicillin antibiotic formerly used for the treatment of severe bacterial infections, notably Pseudomonas aeruginosa. It inhibits bacterial cell wall synthesis. Sulbenicillin is not widely marketed and is largely obsolete, replaced by newer penicillins and cephalosporins.</p><h4>Pharmacokinetics</h4><p>Typical adult population, data based on published pharmacokinetic studies in healthy volunteers and patients with bacterial infections.</p><h4>References</h4><ol><li><p>Nau, H (1987). Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins. <i>Developmental pharmacology and therapeutics</i> 10(3) 174–198. DOI:<a href=&quot;https://doi.org/10.1159/000457744&quot;>10.1159/000457744</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3301235/&quot;>https://pubmed.ncbi.nlm.nih.gov/3301235</a></p></li><li><p>Hansen, IB, et al., &amp; Weis, J (1975). Pharmacokinetics of sulbenicillin, a new broad-spectrum semisynthetic penicillin. <i>Clinical pharmacology and therapeutics</i> 17(3) 339–347. DOI:<a href=&quot;https://doi.org/10.1002/cpt1975173339&quot;>10.1002/cpt1975173339</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1120400/&quot;>https://pubmed.ncbi.nlm.nih.gov/1120400</a></p></li><li><p>Itoh, T, et al., &amp; Yamada, H (1998). Stereoselective disposition of sulbenicillin in humans. <i>Antimicrobial agents and chemotherapy</i> 42(2) 325–331. DOI:<a href=&quot;https://doi.org/10.1128/AAC.42.2.325&quot;>10.1128/AAC.42.2.325</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9527780/&quot;>https://pubmed.ncbi.nlm.nih.gov/9527780</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01CA16;
